SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-297921
Filing Date
2017-09-28
Accepted
2017-09-28 16:54:03
Documents
4
Period of Report
2017-09-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d464991d8k.htm 8-K 17524
2 EX-10.1 d464991dex101.htm EX-10.1 38992
3 EX-10.2 d464991dex102.htm EX-10.2 40512
4 EX-10.3 d464991dex103.htm EX-10.3 32052
  Complete submission text file 0001193125-17-297921.txt   130462
Mailing Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 171108090
SIC: 2834 Pharmaceutical Preparations